PET, MRI study provides clues on Tourette Syndrome

11/21/2012 | Medscape (free registration)

Researchers using PET with carbon-11 flumazenil and structural MRI found that patients with Tourette Syndrome have lower binding of gamma-aminobutyric acid-ergic receptors in the ventral striatum, globus pallidus, thalamus, amygdala and right insula. The study findings are consistent with long-held theories about the disease concerning the disinhibition of particular circuits in the brain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT